Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut. Published Online First: 29 October 2009. doi:10.1136/gut.2009.190827
Copyright © 2009 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Paper

Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?

Nirmala Pandeya, Penelope M Webb, Shahram Sadeghi, Adele C Green, David C Whiteman*

Queensland Institute of Medical Research, Australia

Correspondence to: David C. Whiteman, Population and Cancer Studies, Queensland Institute of Medical Research, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Brisbane, 4029, Australia; david.whiteman{at}qimr.edu.au

Accepted 20 August 2009

ABSTRACT

Objective: To measure the extent to which risks of esophageal cancers associated with gastro-oesophageal reflux (GOR) are modified by common factors including smoking, non-steroidal anti-inflammatory drugs (NSAIDs) and acid suppressant medications.

Design and setting: Population-based case-control study.

Participants: Cases were patients with oesophageal [OAC] (n=365) or gastro-oesophageal junction [GOJAC] (n=426) adenocarcinomas, or squamous cell carcinomas [OSCC] (n=303). Controls were sampled from a population register (n=1580).

Main outcome measure: Odds ratio and 95% confidence interval.

Results: Frequent (at least weekly) symptoms of GOR were associated with significant 6.4-fold, 4.6-fold and 2.2 fold increased risks of OAC, GOJAC and OSCC respectively. Under models examining effects of combined exposure, patients with frequent GOR symptoms who were also heavy smokers had markedly higher OAC risks (OR = 12.3, 6.3 to 24.0) than those with frequent GOR who did not smoke (OR = 6.8, 3.6 to 12.9). Similar patterns were observed for GOJAC and OSCC. Among people with frequent GOR symptoms, regular use of aspirin/NSAIDs was associated with almost two-thirds lower OAC risks (OR = 4.8, 95% CI 2.5 to 9.2) than non-use (13.9, 6.5 to 30.0). In contrast, among those with frequent GOR symptoms, users of acid suppressants had similar OAC risks (7.8, 5.2 to 11.8) to non-users (5.3, 3.2 to 9.0).

Conclusions: People experiencing frequent GOR symptoms have markedly increased risks of OAC and GOJAC, and this effect may be greater amongst smokers. Use of aspirin and NSAIDs, but not acid suppressants, significantly reduced the risks of oesophageal cancers associated with GOR.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs